-
1
-
-
0033504042
-
Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases
-
discussion 318-321.
-
Fong Y, Fortner J, Sun RL, et al.: Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: Analysis of 1001 consecutive cases. Ann Surg 1999; 230: 309-318; discussion 318-321.
-
(1999)
Ann Surg
, vol.230
, pp. 309-318
-
-
Fong, Y.1
Fortner, J.2
Sun, R.L.3
-
2
-
-
37549016003
-
Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: A multifactorial model of 929 patients
-
Rees M, Tekkis PP, Welsh FK, et al.: Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: A multifactorial model of 929 patients. Ann Surg 2008; 247: 125-135.
-
(2008)
Ann Surg
, vol.247
, pp. 125-135
-
-
Rees, M.1
Tekkis, P.P.2
Welsh, F.K.3
-
3
-
-
1342290189
-
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study
-
Tournigand C, Andre T, Achille E, et al.: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 2004; 22: 229-237.
-
(2004)
J Clin Oncol
, vol.22
, pp. 229-237
-
-
Tournigand, C.1
Andre, T.2
Achille, E.3
-
4
-
-
0036104072
-
Trends in long-term survival following liver resection for hepatic colorectal metastases
-
Choti MA, Sitzmann JV, Tiburi MF, et al.: Trends in long-term survival following liver resection for hepatic colorectal metastases. Ann Surg 2002; 235: 759-766.
-
(2002)
Ann Surg
, vol.235
, pp. 759-766
-
-
Choti, M.A.1
Sitzmann, J.V.2
Tiburi, M.F.3
-
5
-
-
33748931490
-
Improving resectability of hepatic colorectal metastases: Expert consensus statement
-
Abdalla EK, Adam R, Bilchik AJ, et al.: Improving resectability of hepatic colorectal metastases: Expert consensus statement. Ann Surg Oncol 2006; 13: 1271-1280.
-
(2006)
Ann Surg Oncol
, vol.13
, pp. 1271-1280
-
-
Abdalla, E.K.1
Adam, R.2
Bilchik, A.J.3
-
6
-
-
78651054955
-
The blood supply of neoplasms in the liver
-
Breedis C, Young G,: The blood supply of neoplasms in the liver. Am J Pathol 1954; 30: 969-977.
-
(1954)
Am J Pathol
, vol.30
, pp. 969-977
-
-
Breedis, C.1
Young, G.2
-
7
-
-
0016371194
-
The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth
-
Ackerman NB,: The blood supply of experimental liver metastases. IV. Changes in vascularity with increasing tumor growth. Surgery 1974; 75: 589-596.
-
(1974)
Surgery
, vol.75
, pp. 589-596
-
-
Ackerman, N.B.1
-
8
-
-
0020552807
-
Clinical pharmacology of hepatic arterial chemotherapy
-
Ensminger WD, Gyves JW,: Clinical pharmacology of hepatic arterial chemotherapy. Semin Oncol 1983; 10: 176-182.
-
(1983)
Semin Oncol
, vol.10
, pp. 176-182
-
-
Ensminger, W.D.1
Gyves, J.W.2
-
9
-
-
0033619892
-
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
-
Kemeny N, Huang Y, Cohen AM, et al.: Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341: 2039-2048.
-
(1999)
N Engl J Med
, vol.341
, pp. 2039-2048
-
-
Kemeny, N.1
Huang, Y.2
Cohen, A.M.3
-
10
-
-
0002745494
-
Arterial devices for regional hepatic chemotherapy: Transaxillary versus laparotomic access
-
Arru M, Aldrighetti L, Gremmo F, et al.: Arterial devices for regional hepatic chemotherapy: Transaxillary versus laparotomic access. J Vasc Access 2000; 1: 93-99.
-
(2000)
J Vasc Access
, vol.1
, pp. 93-99
-
-
Arru, M.1
Aldrighetti, L.2
Gremmo, F.3
-
11
-
-
70350173300
-
Anatomic variations of the hepatic arteries in 250 patients studied with 64-row CT angiography
-
De Cecco C, Ferrari R, Rengo M, et al.: Anatomic variations of the hepatic arteries in 250 patients studied with 64-row CT angiography. Eur Radiol 2009; 19: 2765-2770.
-
(2009)
Eur Radiol
, vol.19
, pp. 2765-2770
-
-
De Cecco, C.1
Ferrari, R.2
Rengo, M.3
-
12
-
-
33645740453
-
Laparoscopic hepatic artery catheterization for regional chemotherapy: Is this the best current option for liver metastatic disease?
-
Franklin M, Trevino J, Hernandez-Oaknin H, et al.: Laparoscopic hepatic artery catheterization for regional chemotherapy: Is this the best current option for liver metastatic disease? Surg Endosc 2006; 20: 554-558.
-
(2006)
Surg Endosc
, vol.20
, pp. 554-558
-
-
Franklin, M.1
Trevino, J.2
Hernandez-Oaknin, H.3
-
13
-
-
4043131513
-
Laparoscopic placement of hepatic artery infusion pumps: Technical considerations and early results
-
Cheng J, Hong D, Zhu G, et al.: Laparoscopic placement of hepatic artery infusion pumps: Technical considerations and early results. Ann Surg Oncol 2004; 11: 589-597.
-
(2004)
Ann Surg Oncol
, vol.11
, pp. 589-597
-
-
Cheng, J.1
Hong, D.2
Zhu, G.3
-
14
-
-
39049118815
-
Robotic-assisted placement of a hepatic artery infusion catheter for regional chemotherapy
-
Hellan M, Pigazzi A,: Robotic-assisted placement of a hepatic artery infusion catheter for regional chemotherapy. Surg Endosc 2008; 22: 548-551.
-
(2008)
Surg Endosc
, vol.22
, pp. 548-551
-
-
Hellan, M.1
Pigazzi, A.2
-
15
-
-
0021135381
-
Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity
-
Daly JM, Kemeny N, Oderman P, et al.: Long-term hepatic arterial infusion chemotherapy. Anatomic considerations, operative technique, and treatment morbidity. Arch Surg 1984; 119: 936-941.
-
(1984)
Arch Surg
, vol.119
, pp. 936-941
-
-
Daly, J.M.1
Kemeny, N.2
Oderman, P.3
-
16
-
-
0027504513
-
Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices
-
Curley SA, Chase JL, Roh MS, et al.: Technical considerations and complications associated with the placement of 180 implantable hepatic arterial infusion devices. Surgery 1993; 114: 928-935.
-
(1993)
Surgery
, vol.114
, pp. 928-935
-
-
Curley, S.A.1
Chase, J.L.2
Roh, M.S.3
-
17
-
-
0037270453
-
Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases
-
Heinrich S, Petrowsky H, Schwinnen I, et al.: Technical complications of continuous intra-arterial chemotherapy with 5-fluorodeoxyuridine and 5-fluorouracil for colorectal liver metastases. Surgery 2003; 133: 40-48.
-
(2003)
Surgery
, vol.133
, pp. 40-48
-
-
Heinrich, S.1
Petrowsky, H.2
Schwinnen, I.3
-
18
-
-
0027214877
-
Regional chemotherapy devices: Effect of experience and anatomy on complications
-
Campbell KA, Burns RC, Sitzmann JV, et al.: Regional chemotherapy devices: Effect of experience and anatomy on complications. J Clin Oncol 1993; 11: 822-826.
-
(1993)
J Clin Oncol
, vol.11
, pp. 822-826
-
-
Campbell, K.A.1
Burns, R.C.2
Sitzmann, J.V.3
-
19
-
-
20544466137
-
Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: An institutional experience of 544 consecutive cases
-
Allen PJ, Nissan A, Picon AI, et al.: Technical complications and durability of hepatic artery infusion pumps for unresectable colorectal liver metastases: An institutional experience of 544 consecutive cases. J Am Coll Surg 2005; 201: 57-65.
-
(2005)
J Am Coll Surg
, vol.201
, pp. 57-65
-
-
Allen, P.J.1
Nissan, A.2
Picon, A.I.3
-
20
-
-
0022988378
-
Directory of on-going research in cancer epidemiology. 1986
-
Muir CS, Wagner G, Demaret E, et al.: Directory of on-going research in cancer epidemiology. 1986. IARC Sci Publ 1986: 1-805.
-
IARC Sci Publ
, vol.1986
, pp. 1-805
-
-
Muir, C.S.1
Wagner, G.2
Demaret, E.3
-
21
-
-
3142708548
-
Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: Comparative results with cisplatin using a rabbit VX2 tumor model
-
Dzodic R, Gomez-Abuin G, Rougier P, et al.: Pharmacokinetic advantage of intra-arterial hepatic oxaliplatin administration: Comparative results with cisplatin using a rabbit VX2 tumor model. Anticancer Drugs 2004; 15: 647-650.
-
(2004)
Anticancer Drugs
, vol.15
, pp. 647-650
-
-
Dzodic, R.1
Gomez-Abuin, G.2
Rougier, P.3
-
22
-
-
24644443860
-
Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: A trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer
-
Ducreux M, Ychou M, Laplanche A, et al.: Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: A trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. J Clin Oncol 2005; 23: 4881-4887.
-
(2005)
J Clin Oncol
, vol.23
, pp. 4881-4887
-
-
Ducreux, M.1
Ychou, M.2
Laplanche, A.3
-
23
-
-
0942266283
-
Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver
-
van Riel JMGH, van Groeningen CJ, de Greve J, et al.: Continuous infusion of hepatic arterial irinotecan in pretreated patients with colorectal cancer metastatic to the liver. Ann Oncol 2004; 15: 59-63.
-
(2004)
Ann Oncol
, vol.15
, pp. 59-63
-
-
Van Riel, J.1
Van Groeningen, C.J.2
De Greve, J.3
-
24
-
-
0022374107
-
A reversible enteropathy complicating continuous hepatic artery infusion chemotherapy with 5-fluoro-2-deoxyuridine
-
Gluck WL, Akwari OE, Kelvin FM, et al.: A reversible enteropathy complicating continuous hepatic artery infusion chemotherapy with 5-fluoro-2-deoxyuridine. Cancer 1985; 56: 2424-2427.
-
(1985)
Cancer
, vol.56
, pp. 2424-2427
-
-
Gluck, W.L.1
Akwari, O.E.2
Kelvin, F.M.3
-
25
-
-
0018774418
-
A new look at the arterial supply of the bile duct in man and its surgical implications
-
Northover JM, Terblanche J,: A new look at the arterial supply of the bile duct in man and its surgical implications. Br J Surg 1979; 66: 379-384.
-
(1979)
Br J Surg
, vol.66
, pp. 379-384
-
-
Northover, J.M.1
Terblanche, J.2
-
26
-
-
0036844353
-
Hepatic artery chemotherapy for colorectal liver metastases: Technical considerations and review of clinical trials
-
Skitzki J, Chang A,: Hepatic artery chemotherapy for colorectal liver metastases: Technical considerations and review of clinical trials. Surg Oncol 2002; 11: 123-135.
-
(2002)
Surg Oncol
, vol.11
, pp. 123-135
-
-
Skitzki, J.1
Chang, A.2
-
27
-
-
0021592866
-
Hepatic artery pump infusion: Toxicity and results in patients with metastatic colorectal carcinoma
-
Kemeny N, Daly J, Oderman P, et al.: Hepatic artery pump infusion: Toxicity and results in patients with metastatic colorectal carcinoma. J Clin Oncol 1984; 2: 595-600.
-
(1984)
J Clin Oncol
, vol.2
, pp. 595-600
-
-
Kemeny, N.1
Daly, J.2
Oderman, P.3
-
28
-
-
0026570019
-
A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer
-
Kemeny N, Seiter K, Niedzwiecki D, et al.: A randomized trial of intrahepatic infusion of fluorodeoxyuridine with dexamethasone versus fluorodeoxyuridine alone in the treatment of metastatic colorectal cancer. Cancer 1992; 69: 327-334.
-
(1992)
Cancer
, vol.69
, pp. 327-334
-
-
Kemeny, N.1
Seiter, K.2
Niedzwiecki, D.3
-
29
-
-
0030249457
-
Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity
-
Davidson BS, Izzo F, Chase JL, et al.: Alternating floxuridine and 5-fluorouracil hepatic arterial chemotherapy for colorectal liver metastases minimizes biliary toxicity. Am J Surg 1996; 172: 244-247.
-
(1996)
Am J Surg
, vol.172
, pp. 244-247
-
-
Davidson, B.S.1
Izzo, F.2
Chase, J.L.3
-
30
-
-
0026016624
-
Alternating hepatic intra-arterial floxuridine and fluorouracil: A less toxic regimen for treatment of liver metastases from colorectal cancer
-
Stagg RJ, Venook AP, Chase JL, et al.: Alternating hepatic intra-arterial floxuridine and fluorouracil: A less toxic regimen for treatment of liver metastases from colorectal cancer. J Natl Cancer Inst 1991; 83: 423-428.
-
(1991)
J Natl Cancer Inst
, vol.83
, pp. 423-428
-
-
Stagg, R.J.1
Venook, A.P.2
Chase, J.L.3
-
31
-
-
70249149719
-
Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma
-
Kemeny N, Melendez FDH, Capanu M, et al.: Conversion to resectability using hepatic artery infusion plus systemic chemotherapy for the treatment of unresectable liver metastases from colorectal carcinoma. J Clin Oncol 2009; 27: 3465-3471.
-
(2009)
J Clin Oncol
, vol.27
, pp. 3465-3471
-
-
Kemeny, N.1
Melendez, F.D.H.2
Capanu, M.3
-
32
-
-
0345505228
-
Patterns of failure following curative resection of colorectal liver metastases
-
Topal B, Kaufman L, Aerts R, et al.: Patterns of failure following curative resection of colorectal liver metastases. Eur J Surg Oncol 2003; 29: 248-253.
-
(2003)
Eur J Surg Oncol
, vol.29
, pp. 248-253
-
-
Topal, B.1
Kaufman, L.2
Aerts, R.3
-
33
-
-
0035108283
-
Repeat hepatectomy for colorectal liver metastases: A worthwhile operation?
-
Muratore A, Polastri R, Bouzari H, et al.: Repeat hepatectomy for colorectal liver metastases: A worthwhile operation? J Surg Oncol 2001; 76: 127-132.
-
(2001)
J Surg Oncol
, vol.76
, pp. 127-132
-
-
Muratore, A.1
Polastri, R.2
Bouzari, H.3
-
34
-
-
0029010380
-
Resection versus resection combined with adjuvant pre- and post-operative chemotherapy-immunotherapy for metastatic colorectal liver cancer. A new look at an old problem
-
Lygidakis NJ, Ziras N, Parissis J,: Resection versus resection combined with adjuvant pre- and post-operative chemotherapy-immunotherapy for metastatic colorectal liver cancer. A new look at an old problem. Hepatogastroenterology 1995; 42: 155-161.
-
(1995)
Hepatogastroenterology
, vol.42
, pp. 155-161
-
-
Lygidakis, N.J.1
Ziras, N.2
Parissis, J.3
-
35
-
-
0035658785
-
Metastatic liver disease of colorectal origin: The value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study
-
Lygidakis NJ, Sgourakis G, Vlachos L, et al.: Metastatic liver disease of colorectal origin: The value of locoregional immunochemotherapy combined with systemic chemotherapy following liver resection. Results of a prospective randomized study. Hepatogastroenterology 2001; 48: 1685-1691.
-
(2001)
Hepatogastroenterology
, vol.48
, pp. 1685-1691
-
-
Lygidakis, N.J.1
Sgourakis, G.2
Vlachos, L.3
-
36
-
-
13744255337
-
Hepatic arterial infusion after liver resection
-
Kemeny NE, Gonen M,: Hepatic arterial infusion after liver resection. N Engl J Med 2005; 352: 734-735.
-
(2005)
N Engl J Med
, vol.352
, pp. 734-735
-
-
Kemeny, N.E.1
Gonen, M.2
-
37
-
-
0037087721
-
Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-An intergroup study
-
Kemeny MM, Adak S, Gray B, et al.: Combined-modality treatment for resectable metastatic colorectal carcinoma to the liver: Surgical resection of hepatic metastases in combination with continuous infusion of chemotherapy-An intergroup study. J Clin Oncol 2002; 20: 1499-1505.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1499-1505
-
-
Kemeny, M.M.1
Adak, S.2
Gray, B.3
-
38
-
-
0343729320
-
Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen)
-
Lorenz M, Muller HH, Schramm H, et al.: Randomized trial of surgery versus surgery followed by adjuvant hepatic arterial infusion with 5-fluorouracil and folinic acid for liver metastases of colorectal cancer. German Cooperative on Liver Metastases (Arbeitsgruppe Lebermetastasen). Ann Surg 1998; 228: 756-762.
-
(1998)
Ann Surg
, vol.228
, pp. 756-762
-
-
Lorenz, M.1
Muller, H.H.2
Schramm, H.3
-
39
-
-
35648981122
-
Actual 10-year survival after resection of colorectal liver metastases defines cure
-
Tomlinson JS, Jarnagin WR, DeMatteo RP, et al.: Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 2007; 25: 4575-4580.
-
(2007)
J Clin Oncol
, vol.25
, pp. 4575-4580
-
-
Tomlinson, J.S.1
Jarnagin, W.R.2
Dematteo, R.P.3
-
40
-
-
44449167220
-
Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer
-
DOI 10.1097/SLA.0b013e31816c405f, PII 0000065820080600000013
-
Ito H, Are C, Gonen M, et al.: Effect of postoperative morbidity on long-term survival after hepatic resection for metastatic colorectal cancer. Ann Surg 2008; 247: 994-1002. (Pubitemid 351770420)
-
(2008)
Annals of Surgery
, vol.247
, Issue.6
, pp. 994-1002
-
-
Ito, H.1
Are, C.2
Gonen, M.3
D'Angelica, M.4
DeMatteo, R.P.5
Kemeny, N.E.6
Fong, Y.7
Blumgart, L.H.8
Jarnagin, W.R.9
-
41
-
-
77952324326
-
Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer
-
House MG, Kemeny N, Jarnagin W, et al.: Comparison of adjuvant systemic chemotherapy with or without hepatic arterial infusional chemotherapy after hepatic resection for metastatic colorectal cancer. American Society of Clinical Oncology 2009 Gastrointestinal Cancers Symposium, 2009.
-
(2009)
American Society of Clinical Oncology 2009 Gastrointestinal Cancers Symposium
-
-
House, M.G.1
Kemeny, N.2
Jarnagin, W.3
-
42
-
-
0141799961
-
Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer
-
Kemeny N, Jarnagin W, Gonen M, et al.: Phase I/II study of hepatic arterial therapy with floxuridine and dexamethasone in combination with intravenous irinotecan as adjuvant treatment after resection of hepatic metastases from colorectal cancer. J Clin Oncol 2003; 21: 3303-3309.
-
(2003)
J Clin Oncol
, vol.21
, pp. 3303-3309
-
-
Kemeny, N.1
Jarnagin, W.2
Gonen, M.3
-
43
-
-
67650354362
-
Phase i trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer
-
Kemeny N, Capanu M, D'Angelica M, et al.: Phase I trial of adjuvant hepatic arterial infusion (HAI) with floxuridine (FUDR) and dexamethasone plus systemic oxaliplatin, 5-fluorouracil and leucovorin in patients with resected liver metastases from colorectal cancer. Ann Oncol 2009; 20: 1236-1241.
-
(2009)
Ann Oncol
, vol.20
, pp. 1236-1241
-
-
Kemeny, N.1
Capanu, M.2
D'Angelica, M.3
-
44
-
-
35348905517
-
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases
-
Barone C, Nuzzo G, Cassano A, et al.: Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases. Br J Cancer 2007; 97: 1035-1039.
-
(2007)
Br J Cancer
, vol.97
, pp. 1035-1039
-
-
Barone, C.1
Nuzzo, G.2
Cassano, A.3
-
45
-
-
36749067866
-
Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer
-
Tabernero J, Van Cutsem E, Diaz-Rubio E, et al.: Phase II trial of cetuximab in combination with fluorouracil, leucovorin, and oxaliplatin in the first-line treatment of metastatic colorectal cancer. J Clin Oncol 2007; 25: 5225-5232.
-
(2007)
J Clin Oncol
, vol.25
, pp. 5225-5232
-
-
Tabernero, J.1
Van Cutsem, E.2
Diaz-Rubio, E.3
-
46
-
-
37349026722
-
Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: A retrospective analysis
-
Gallagher DJ, Capanu M, Raggio G, et al.: Hepatic arterial infusion plus systemic irinotecan in patients with unresectable hepatic metastases from colorectal cancer previously treated with systemic oxaliplatin: A retrospective analysis. Ann Oncol 2007; 18: 1995-1999.
-
(2007)
Ann Oncol
, vol.18
, pp. 1995-1999
-
-
Gallagher, D.J.1
Capanu, M.2
Raggio, G.3
-
47
-
-
38049164083
-
Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure
-
Boige V, Malka D, Elias D, et al.: Hepatic arterial infusion of oxaliplatin and intravenous LV5FU2 in unresectable liver metastases from colorectal cancer after systemic chemotherapy failure. Ann Surg Oncol 2008; 15: 219-226.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 219-226
-
-
Boige, V.1
Malka, D.2
Elias, D.3
-
48
-
-
0023552654
-
A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases
-
Chang AE, Schneider PD, Sugarbaker PH, et al.: A prospective randomized trial of regional versus systemic continuous 5-fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206: 685-693.
-
(1987)
Ann Surg
, vol.206
, pp. 685-693
-
-
Chang, A.E.1
Schneider, P.D.2
Sugarbaker, P.H.3
-
49
-
-
0023191990
-
Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial
-
Kemeny N, Daly J, Reichman B, et al.: Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma. A randomized trial. Ann Intern Med 1987; 107: 459-465. (Pubitemid 17149758)
-
(1987)
Annals of Internal Medicine
, vol.107
, Issue.4
, pp. 459-465
-
-
Kemeny, N.1
Daly, J.2
Reichman, B.3
Geller, N.4
Botet, J.5
Oderman, P.6
-
50
-
-
0024425297
-
A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial
-
Hohn DC, Stagg RJ, Friedman MA, et al.: A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: The Northern California Oncology Group trial. J Clin Oncol 1989; 7: 1646-1654.
-
(1989)
J Clin Oncol
, vol.7
, pp. 1646-1654
-
-
Hohn, D.C.1
Stagg, R.J.2
Friedman, M.A.3
-
51
-
-
0026625223
-
Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial
-
Rougier P, Laplanche A, Huguier M, et al.: Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: Long-term results of a prospective randomized trial. J Clin Oncol 1992; 10: 1112-1118.
-
(1992)
J Clin Oncol
, vol.10
, pp. 1112-1118
-
-
Rougier, P.1
Laplanche, A.2
Huguier, M.3
-
52
-
-
0028150629
-
Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases
-
Allen-Mersh TG, Earlam S, Fordy C, et al.: Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255-1260.
-
(1994)
Lancet
, vol.344
, pp. 1255-1260
-
-
Allen-Mersh, T.G.1
Earlam, S.2
Fordy, C.3
-
53
-
-
0343048340
-
Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma
-
Lorenz M, Muller HH,: Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 2000; 18: 243-254.
-
(2000)
J Clin Oncol
, vol.18
, pp. 243-254
-
-
Lorenz, M.1
Muller, H.H.2
-
54
-
-
0037308489
-
Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: A multicentre randomised trial
-
Kerr DJ, McArdle CS, Ledermann J, et al.: Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: A multicentre randomised trial. Lancet 2003; 361: 368-373.
-
(2003)
Lancet
, vol.361
, pp. 368-373
-
-
Kerr, D.J.1
McArdle, C.S.2
Ledermann, J.3
-
55
-
-
33645450153
-
Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481)
-
Kemeny NE, Niedzwiecki D, Hollis DR, et al.: Hepatic arterial infusion versus systemic therapy for hepatic metastases from colorectal cancer: A randomized trial of efficacy, quality of life, and molecular markers (CALGB 9481). J Clin Oncol 2006; 24: 1395-1403.
-
(2006)
J Clin Oncol
, vol.24
, pp. 1395-1403
-
-
Kemeny, N.E.1
Niedzwiecki, D.2
Hollis, D.R.3
-
56
-
-
1342290189
-
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study
-
Tournigand C, Andr T, Achille E, et al.: FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study. J Clin Oncol 2004; 22: 229-237.
-
(2004)
J Clin Oncol
, vol.22
, pp. 229-237
-
-
Tournigand, C.1
Andr, T.2
Achille, E.3
-
57
-
-
2542561964
-
Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer
-
Hurwitz H, Fehrenbacher L, Novotny W, et al.: Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 2004; 350: 2335-2342.
-
(2004)
N Engl J Med
, vol.350
, pp. 2335-2342
-
-
Hurwitz, H.1
Fehrenbacher, L.2
Novotny, W.3
-
58
-
-
33846055070
-
Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: Results of a multi-centric randomized study
-
Fiorentini G, Cantore M, Rossi S, et al.: Hepatic arterial chemotherapy in combination with systemic chemotherapy compared with hepatic arterial chemotherapy alone for liver metastases from colorectal cancer: Results of a multi-centric randomized study. In Vivo 2006; 20: 707-709.
-
(2006)
Vivo
, vol.20
, pp. 707-709
-
-
Fiorentini, G.1
Cantore, M.2
Rossi, S.3
-
59
-
-
53049092394
-
Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: A randomized phase III noninferiority study
-
Rothenberg ML, Cox JV, Butts C, et al.: Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: A randomized phase III noninferiority study. Ann Oncol 2008; 19: 1720-1726.
-
(2008)
Ann Oncol
, vol.19
, pp. 1720-1726
-
-
Rothenberg, M.L.1
Cox, J.V.2
Butts, C.3
-
60
-
-
24644484863
-
Phase i trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer
-
Kemeny N, Jarnagin W, Paty P, et al.: Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. J Clin Oncol 2005; 23: 4888-4896.
-
(2005)
J Clin Oncol
, vol.23
, pp. 4888-4896
-
-
Kemeny, N.1
Jarnagin, W.2
Paty, P.3
-
61
-
-
0035873927
-
Phase i study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer
-
Kemeny N, Gonen M, Sullivan D, et al.: Phase I study of hepatic arterial infusion of floxuridine and dexamethasone with systemic irinotecan for unresectable hepatic metastases from colorectal cancer. J Clin Oncol 2001; 19: 2687-2695.
-
(2001)
J Clin Oncol
, vol.19
, pp. 2687-2695
-
-
Kemeny, N.1
Gonen, M.2
Sullivan, D.3
|